GE HealthCare Technologies Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +0.8%
EBITDA: -10.9%
EBIT: -8.4%
EPS: -31.0%
Free cash flow: +10.6%
Operating cash flow: +13.8%

Forward estimates

Revenue: +10.5%
EBITDA: +19.9%
EPS: +61.5%

Three-year CAGR

Revenue: +4.0%
EBITDA: +6.1%
EBIT: +3.1%
Net income: +2.8%
EPS: +2.6%
Free cash flow: -5.8%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.